Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (490) 490
Book Review (138) 138
Book Chapter (16) 16
Conference Proceeding (11) 11
Publication (9) 9
Web Resource (4) 4
Book / eBook (1) 1
Patent (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (290) 290
index medicus (289) 289
rheumatology (166) 166
female (143) 143
male (128) 128
middle aged (121) 121
rheumatoid arthritis (114) 114
adult (98) 98
aged (83) 83
fibromyalgia (79) 79
immunology (78) 78
arthritis, rheumatoid - drug therapy (67) 67
treatment outcome (66) 66
antirheumatic agents - therapeutic use (59) 59
rheumatoid factor (54) 54
pain (51) 51
risk factors (49) 49
arthritis (48) 48
prevalence (46) 46
severity of illness index (40) 40
italy (39) 39
rheumatoid-arthritis (38) 38
care and treatment (37) 37
double-blind (36) 36
allergy and immunology (35) 35
infliximab (35) 35
tumor necrosis factor-alpha - antagonists & inhibitors (35) 35
therapy (34) 34
fibromyalgia - diagnosis (33) 33
fibromyalgia - physiopathology (33) 33
quality of life (33) 33
etanercept (32) 32
animals (31) 31
autoimmunity (30) 30
efficacy (30) 30
arthritis, rheumatoid - immunology (28) 28
medicine (27) 27
rituximab (27) 27
methotrexate (26) 26
adalimumab (25) 25
analysis (25) 25
pain measurement (25) 25
drug therapy (24) 24
inflammation (24) 24
antibodies, monoclonal - therapeutic use (23) 23
disease (23) 23
internal medicine (23) 23
safety (23) 23
antirheumatic agents - adverse effects (22) 22
psoriatic arthritis (22) 22
risk (22) 22
surveys and questionnaires (22) 22
systemic-lupus-erythematosus (22) 22
aged, 80 and over (21) 21
chronic pain (21) 21
criteria (21) 21
fibromyalgia - therapy (21) 21
comorbidity (20) 20
drug therapy, combination (20) 20
patients (20) 20
research (20) 20
systemic lupus erythematosus (20) 20
time factors (20) 20
young adult (20) 20
association (19) 19
atherosclerosis (19) 19
autoimmune diseases (19) 19
biomarkers - blood (19) 19
fibromyalgia - psychology (19) 19
adolescent (18) 18
prognosis (18) 18
tumor necrosis factor (18) 18
antibodies (17) 17
arthritis, rheumatoid - blood (17) 17
arthritis, rheumatoid - physiopathology (17) 17
diagnosis (17) 17
health aspects (17) 17
infections (17) 17
medicine & public health (17) 17
modifying antirheumatic drugs (17) 17
research article (17) 17
abridged index medicus (16) 16
antibodies, monoclonal, humanized (16) 16
arthritis, rheumatoid - complications (16) 16
arthritis, rheumatoid - diagnosis (16) 16
classification (16) 16
disease-activity (16) 16
fibromyalgia - complications (16) 16
management (16) 16
medical research (16) 16
pharmacology & pharmacy (16) 16
predictive value of tests (16) 16
ankylosing-spondylitis (15) 15
chronic pain - diagnosis (15) 15
lupus (15) 15
medicine, experimental (15) 15
medicine, general & internal (15) 15
placebo-controlled trial (15) 15
registries (15) 15
remission (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The Prevalence of Fibromyalgia in the General Population: A Comparison of the American College of Rheumatology 1990, 2010, and Modified 2010 Classification Criteria
by Jones, Gareth T and Atzeni, Fabiola and Beasley, Marcus and Flüß, Elisa and Sarzi‐Puttini, Piercarlo and Macfarlane, Gary J
Arthritis & Rheumatology, ISSN 2326-5191, 02/2015, Volume 67, Issue 2, pp. 568 - 575
Objective. The American College of Rheumatology (ACR) 1990 fibromyalgia classification criteria are based on the presence of widespread pain and tenderness. In... 
SYMPTOM SEVERITY | SCALE | RHEUMATOLOGY | PRELIMINARY DIAGNOSTIC-CRITERIA | Prevalence | Cross-Sectional Studies | Fibromyalgia - epidemiology | United States | Humans | Middle Aged | Male | Scotland - epidemiology | Fibromyalgia - classification | Fibromyalgia - diagnosis | Adult | Female | Surveys and Questionnaires | Aged | Retrospective Studies | Confidence intervals | Fibromyalgia | Pain | Classification | Rheumatology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The therapeutic journey of biologic agents: There will be an end?
by Atzeni, Fabiola and Sarzi-Puttini, Piercarlo
Pharmacological Research, ISSN 1043-6618, 09/2019, Volume 147, pp. 104340 - 104340
DMARDs | Biosimilar | Cytokine | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Neurobiological similarities between RA and fibromyalgia
by Atzeni, Fabiola and Sarzi-Puttini, Piercarlo
Nature Reviews Rheumatology, ISSN 1759-4790, 06/2018, Volume 14, Issue 6, pp. 324 - 325
Pain management can be a difficult problem for patients with rheumatoid arthritis (RA), some of whom can experience pain similar to that reported by patients... 
Fibromyalgia | Care and treatment | Pain | Comparative analysis | Rheumatoid arthritis | Methods | Patients | Neurobiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. The skin in systemic autoimmune diseases
by Sarzi-Puttini, Piercarlo
2006, 1st ed., Handbook of systemic autoimmune diseases, ISBN 0444521585, Volume 5
Immunological aspects | Skin Manifestations | Skin | Cutaneous manifestations of general diseases | Autoimmune diseases | immunology | Diseases
Web Resource
Details down arrow
5. The skin in systemic autoimmune diseases
by Sarzi-Puttini, Piercarlo and ScienceDirect (Online service)
2006, 1st ed., Handbook of systemic autoimmune diseases, ISBN 0444521585, Volume 5
This book represents the state-of-the-art in the field of skin and autoimmune rheumatic diseases. It covers systematically a growing and multifaceted topic... 
Immunological aspects | Skin Manifestations | Skin | Cutaneous manifestations of general diseases | Autoimmune diseases | immunology | Diseases
Web Resource
Details down arrow
6. Anti-cytokine therapy in rheumatoid arthritis
by Sarzi-Puttini, Piercarlo and Atzeni, Fabiola
2007, Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies
Autoimmunity | drug therapy | Autoimmune Diseases | Research | Arthritis, Rheumatoid
Web Resource
Details down arrow
7. Anti-cytokine therapy in rheumatoid arthritis
by Sarzi-Puttini, Piercarlo and Atzeni, Fabiola
2007, Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies
Autoimmunity | drug therapy | Autoimmune Diseases | Research | Arthritis, Rheumatoid
Web Resource
Details down arrow
8. Full Text Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren’s Syndrome through an Impaired Epigenetic Control: The State-of-The-Art
by Talotta, Rossella and Sarzi-Puttini, Piercarlo and Atzeni, Fabiola
Journal of Immunology Research, ISSN 2314-8861, 01/2019, Volume 2019, pp. 1 - 11
Introduction. Understanding the mechanisms underlying the pathogenesis of Sjögren’s syndrome (SS) is crucially important in order to be able to discriminate... 
Transformation | Dysbacteriosis | Sjogren's syndrome | Disease | Pathogenesis | Epithelial cells | DNA damage | Viruses | Genomes | Infections | Cell activation | Microorganisms | Microbiota | Lymphocytes | DNA methylation | Search engines | Genetics | Tumorigenesis | Deoxyribonucleic acid--DNA | Inducers | Immune system | Phenotypes | Immune response | Cytokines | Salivary glands | Rheumatology | Salivary gland | Inflammation | Gene expression | Patients | Lymphoma | Immune systems | Scientific papers | Lymphocytes B | Epigenetics | Lymphomas | Autoimmune diseases | Viral infections | B-cell lymphoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Impact of Moving From a Widespread to Multisite Pain Definition on Other Fibromyalgia Symptoms
by Dean, Linda E and Arnold, Lesley and Crofford, Leslie and Bennett, Robert and Goldenberg, Don and Fitzcharles, Mary‐Ann and Paiva, Eduardo S and Staud, Roland and Clauw, Dan and Sarzi‐Puttini, Piercarlo and Jones, Gareth T and Ayorinde, Abimbola and Flüß, Elisa and Beasley, Marcus and Macfarlane, Gary J
Arthritis Care & Research, ISSN 2151-464X, 12/2017, Volume 69, Issue 12, pp. 1878 - 1886
Objective. To investigate whether associations between pain and the additional symptoms associated with fibromyalgia are different in persons with chronic... 
CRITERIA | DIAGNOSIS | OF-RHEUMATOLOGY 1990 | VALIDATION | CLASSIFICATION | GENDER | PREVALENCE | SCALE | RHEUMATOLOGY | Pain | Sleep | Mood | Womens health | Low back pain | Fibromyalgia | Fatigue | Population studies | Children | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: Systematic review and meta-analysis
by Häuser, Winfried and Sarzi-Puttini, Piercarlo and Tölle, Thomas R and Wolfe, Fred
Clinical and Experimental Rheumatology, ISSN 0392-856X, 2012, Volume 30, Issue 74, pp. S78 - S87
Placebo response | Systematic review | Fibromyalgia syndrome | Nocebo response | Meta-analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Rheumatoid arthritis: Why wait? Explaining delays in seeking therapy for early arthritis
by Atzeni, Fabiola and Sarzi-Puttini, Piercarlo
Nature Reviews Rheumatology, ISSN 1759-4790, 04/2012, Volume 8, Issue 4, pp. 190 - 191
Health Services Accessibility - statistics & numerical data | Self Medication - statistics & numerical data | Arthritis, Rheumatoid - drug therapy | Humans | Risk Factors | Arthritis, Rheumatoid - epidemiology | Delayed Diagnosis | Patient Acceptance of Health Care - statistics & numerical data | Arthritis, Rheumatoid - diagnosis | Early Diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib
by Combe, Bernard and Balsa, Alejandro and Sarzi-Puttini, Piercarlo and Tony, Hans-Peter and de la Torre, Inmaculada and Rogai, Veronica and Durand, Frederick and Witt, Sarah and Zhong, Jinglin and Dougados, Maxime
Annals of the Rheumatic Diseases, ISSN 0003-4967, 08/2019, Volume 78, Issue 8, pp. 1135 - 1138
Terms for hepatic disorders included alanine aminotransferase increased, aspartate aminotransferase increased, biliary cirrhosis primary, blood alkaline... 
treatment | rheumatoid arthritis | DMARDs (synthetic) | Brain | Alkaline phosphatase | Transient ischemic attack | Cardiomyopathy | Clinical trials | Hemorrhage | Blood | Osteoporosis | Dura mater | Heart diseases | Cerebral infarction | Stroke | Alanine | Liver diseases | Comorbidity | Lung diseases | Coronary artery | Nevus | Patients | Coronary artery disease | Cholesterol | Studies | Cirrhosis | Rheumatoid arthritis | Response rates | Alanine transaminase | Aspartate aminotransferase | Cardiovascular diseases | Cholestasis | Letter | 1506 | 2311
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO‐VADIS study, a large, prospective real‐life cohort
by Claudepierre, Pascal and Van den Bosch, Filip and Sarzi‐Puttini, Piercarlo and Vastesaeger, Nathan and Govoni, Marinella and Kachroo, Sumesh
International Journal of Rheumatic Diseases, ISSN 1756-1841, 06/2019, Volume 22, Issue 6, pp. 995 - 1001
Aim We evaluated the effects of anti-tumor necrosis factor (TNF) agents on health economics in ankylosing spondylitis (AS) patients. Methods QUality of Life as... 
absenteeism | presenteeism | infliximab | ankylosing spondylitis | anti‐TNF treatments | healthcare resource utilization | health‐related quality of life | work productivity and activity impairment | golimumab | anti-TNF treatments | health-related quality of life | EFFICACY | SAFETY | SICK LEAVE | RHEUMATOLOGY | ARTHRITIS | ANTITUMOR NECROSIS FACTOR | IMPACT | COSTS | DISABILITY | Medical care | Care and treatment | Infliximab | Analysis | Ankylosing spondylitis | Quality management | Productivity | Resource utilization | Rheumatic diseases | Arthritis | Tumor necrosis factor-α | Patients | Inflammatory diseases | Quality of life | Spondylitis | Monoclonal antibodies | Tumor necrosis factor-TNF
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment
by Mathews, Rebeccah J and Robinson, James I and Battellino, Michele and Wong, Chi and Taylor, John C and Eyre, Steve and Churchman, Sarah M and Wilson, Anthony G and Isaacs, John D and Hyrich, Kimme and Barton, Anne and Plant, Darren and Savic, Sinisa and Cook, Graham P and Sarzi-Puttini, Piercarlo and Emery, Paul and Barrett, Jennifer H and Morgan, Ann W and McDermott, Michael F and BRAGGSS and Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS)
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2014, Volume 73, Issue 6, pp. 1202 - 1210
Background The NLRP3-inflammasome, implicated in the pathogenesis of several inflammatory disorders, has been analysed in rheumatoid arthritis (RA). Methods... 
VISUALIZATION | INFLAMMASOME | DISEASE | METHOTREXATE | NECROSIS-FACTOR-ALPHA | CARD8 P.C10X | RHEUMATOLOGY | INFLIXIMAB | EXPRESSION | GENOME-WIDE ASSOCIATION | PATHOPHYSIOLOGY | Multivariate Analysis | Cytoskeletal Proteins - genetics | NLR Family, Pyrin Domain-Containing 3 Protein | Humans | Middle Aged | RNA, Messenger - analysis | Male | Gene Expression Profiling | Case-Control Studies | CARD Signaling Adaptor Proteins - genetics | Arthritis, Rheumatoid - drug therapy | Adult | Female | Neoplasm Proteins - genetics | Antirheumatic Agents - therapeutic use | Genetic Predisposition to Disease | Genotype | Linear Models | Inflammasomes - genetics | Pyrin | Carrier Proteins - genetics | Arthritis, Rheumatoid - genetics | Caspase 1 - genetics | Aged | Polymorphism, Single Nucleotide | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Complications and side effects | Care and treatment | Tumor necrosis factor inhibitors | Rheumatoid arthritis | Analysis | Inflammation | Dosage and administration | Proteins | Studies | Biomedical research | Disease | Pathogenesis | Genes | Genomics | Tumor necrosis factor-TNF | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Complementary and alternative medicine for the treatment of fibromyalgia
by Langhorst, Jost and Häuser, Winfried and Lauche, Romy and Perrot, Serge and Alegre, Cayetano and Sarzi Puttini, Piercarlo C
Evidence-based Complementary and Alternative Medicine, ISSN 1741-427X, 2014, Volume 2014, pp. 408436 - 2
A recent consumers report indicated that 67.0% of German FMS patients used heat application or thermal baths, 35.2% different CAM medications such as... 
CRITERIA | INTEGRATIVE & COMPLEMENTARY MEDICINE | PREVALENCE | Fibromyalgia | Practice | Care and treatment | Alternative medicine | Pain | Rheumatology | Clinical trials | Rheumatism | Arthritis | Yoga | Patients | Quality of life
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity
by Salaffi, Fausto and De Angelis, Rossella and Carotti, Marina and Gutierrez, Marwin and Sarzi-Puttini, Piercarlo and Atzeni, Fabiola
Rheumatology International, ISSN 0172-8172, 8/2014, Volume 34, Issue 8, pp. 1103 - 1110
To determine the prevalence of fibromyalgia (FM) in patients with ankylosing spondylitis (AS) or psoriatic arthritis (PsA) characterized by axial involvement... 
BASDAI | Prevalence | Disease activity | Medicine & Public Health | Rheumatology | Fibromyalgia | Spondyloarthritis | ASDAS | RHEUMATOID-ARTHRITIS | CHRONIC WIDESPREAD PAIN | ANKYLOSING-SPONDYLITIS | CLINICAL-FEATURES | RHEUMATOLOGY | PSORIATIC-ARTHRITIS | GENERAL-POPULATION | QUALITY-OF-LIFE | DIAGNOSTIC-CRITERIA | ACTIVITY SCORE ASDAS | Arthritis, Psoriatic - epidemiology | Blood Sedimentation | Predictive Value of Tests | Humans | Middle Aged | Spondylitis, Ankylosing - blood | Arthritis, Psoriatic - diagnosis | Male | Fibromyalgia - blood | Spondylitis, Ankylosing - epidemiology | Adult | Female | C-Reactive Protein - analysis | Disability Evaluation | Severity of Illness Index | Cross-Sectional Studies | Fibromyalgia - epidemiology | Inflammation Mediators - blood | Biomarkers - blood | Fibromyalgia - diagnosis | Spondylitis, Ankylosing - diagnosis | Arthritis, Psoriatic - blood | Italy - epidemiology | Aged | Measurement | C-reactive protein | Medical examination | Psoriasis | Discrimination in insurance | Epidemiology | Blood | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia
by Salaffi, Fausto and Di Carlo, Marco and Carotti, Marina and Sarzi-Puttini, Piercarlo
Rheumatology International, ISSN 0172-8172, 10/2018, Volume 38, Issue 10, pp. 1911 - 1918
To determine the contribution of fibromyalgia (FM) to the subjective components of the Disease Activity Score 28-joints (DAS28) in patients with rheumatoid... 
Fibromyalgia | Disease Activity Score 28-joints | Medicine & Public Health | Rheumatoid arthritis | Rheumatology | POPULATION | AMERICAN-COLLEGE | 28 JOINTS | PREVALENCE | RHEUMATOLOGY | PAIN | RECOMMENDATIONS | MUSCULOSKELETAL CONDITIONS | COHORT | HEALTH | QUESTIONNAIRE | Severity of Illness Index | Fibromyalgia - epidemiology | Comorbidity | Fibromyalgia - pathology | Humans | Middle Aged | Arthritis, Rheumatoid - epidemiology | Joints - pathology | Male | Arthritis, Rheumatoid - pathology | Pain | Female | Health Status | Pain Measurement | Medicine, Experimental | Medical research | Rheumatoid factor | Arthritis | Analysis | Patients | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Comparison of methods and TAT assessment: Volumetric AQUIOS CL and bead‐based FACS CANTO II cytometers
by Grossi, Valentina and Infantino, Maria and Meacci, Francesca and Bellio, Emanuele and Bellio, Valerio and Ciotta, Giovanna and Priami, Fiorella and Sarzi‐Puttini, Piercarlo and Atzeni, Fabiola and Li Gobbi, Francesca and Damiani, Arianna and Benucci, Maurizio and Manfredi, Mariangela
Cytometry Part B: Clinical Cytometry, ISSN 1552-4949, 07/2018, Volume 94, Issue 4, pp. 674 - 678
BackgroundMeasurement of lymphocyte subpopulations is a crucial parameter in the diagnosis and monitoring of therapy in a wide variety of clinical conditions.... 
AQUIOS | flow cytometry | percentage count | absolute count | INFLAMMATION | VALIDATION | ICCS | MEDICAL LABORATORY TECHNOLOGY | PATHOLOGY | ICSH | ASSAYS PRACTICE GUIDELINES | Subpopulations | Flow cytometry | Reduction | Automation | Immunology | Laboratories | Mathematical analysis | Flow | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis
by Quartuccio, Luca and Fabris, Martina and Salvin, Sara and Atzeni, Fabiola and Saracco, Marta and Benucci, Maurizio and Cimmino, Marco and Morassi, Pia and Masolini, Paola and Pellerito, Raffaele and Cutolo, Maurizio and Sarzi-Puttini, Piercarlo and De Vita, Salvatore
Rheumatology, ISSN 1462-0324, 2009, Volume 48, Issue 12, pp. 1557 - 1559
Objectives. We explored clinical factors associated with a major response to rituximab (RTX) (e.g. ACR >= 50, and European League against Rheumatism (EULAR)... 
Anti-TNF | Rituximab | Rheumatoid factor | Anti-CCP | DMARDs | Rheumatoid arthritis | EFFICACY | SAFETY | REGENERATION | B-CELL DEPLETION | RHEUMATOLOGY | TRIAL | PHASE | THERAPY | PREDICTORS | DOUBLE-BLIND | Rheumatoid Factor - blood | Prognosis | Autoantibodies - blood | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Patient Selection | Young Adult | Arthritis, Rheumatoid - drug therapy | Treatment Failure | Aged, 80 and over | Adult | Female | Retrospective Studies | Antirheumatic Agents - therapeutic use | Disability Evaluation | Antibodies, Monoclonal, Murine-Derived | Peptides, Cyclic - immunology | Treatment Outcome | Biomarkers - blood | Aged | Arthritis, Rheumatoid - immunology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients
by Schweiger, V and Martini, A and Bellamoli, P and Donadello, K and Schievano, C and Bazo, GD and Sarzi-Puttini, P and Parolini, M and Polati, E
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, ISSN 1871-5273, 2019, Volume 18, Issue 4, pp. 326 - 333
Background: Fibromyalgia syndrome is a chronic multifaceted disease characterized by widespread pain, muscle stiffness, fatigue, unrefreshing sleep and... 
SYSTEM | Mast-cells (MC) | EFFICACY | ANANDAMIDE | Symptoms Severity Score (SS) | RECEPTOR | NEUROSCIENCES | ultramicronized Palmitoylethanolamide (um-PEA) | IMMUNE | NEUROPATHIC PAIN | IMPACT | Fibromyalgia syndrome (FMS) | NEUROINFLAMMATION | Adverse Events (AEs) | Fibromyalgia Impact Questionnaire (FIQ) | Visual Analogue Scale (VAS) | PHARMACOLOGY & PHARMACY | Widespread Pain Index (WPI) | MODULATION
Journal Article
Details down arrow